✉news HealthMedicine first seen 6 h ago, last 1 h ago, peak #5
Phase 1 trial launches for Werner helicase inhibitor targeting MSI tumors
Original: Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial
A phase 1 clinical trial is testing a Werner helicase inhibitor in patients with advanced microsatellite instability (MSI) solid tumors. The early-stage study, published in Nature, evaluates safety, dosing and early anti-tumor activity of the investigational drug. Werner helicase is a DNA repair protein, and blocking it is a new synthetic-lethality approach for cancers that have already resisted standard treatments, including immunotherapy.
Why now: New early clinical data for a first-in-class DNA repair-targeting cancer drug was just published in a major journal.
Werner helicasemicrosatellite instability solid tumorsNaturephase 1 trial
Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 1 h ago.
Evidence
- Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial · Nature
API: https://socialmediatrends-api.osmike.com/v1/trends/379668